<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8506326" created="29/01/2007" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8506326</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A11" sem="Other">Molecular basis</term> of a multiple <term id="T1" lex="lymphokine_deficiency" sem="Other"><term id="T2" lex="lymphokine" sem="Protein_family_or_group">lymphokine</term> deficiency</term> in a patient with <term id="T3" lex="severe_combined_immunodeficiency" sem="Other">severe combined immunodeficiency</term>.</sentence>
<event KT="Investigation" id="E15">
<type class="Regulation"/>
<theme idref="T1"/>
<cause idref="A11"/>
<clue>Molecular basis <linkTheme>of</linkTheme> a multiple lymphokine deficiency <clueLoc>in a patient with severe combined immunodeficiency</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We have previously reported that the <term id="T4" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> of a child with <term id="T5" lex="severe_combined_immunodeficiency" sem="Other">severe combined immunodeficiency</term> are defective in the transcription of several <term id="T6" lex="lymphokine_gene" sem="DNA_family_or_group"><term id="T7" lex="lymphokine" sem="Protein_family_or_group">lymphokine</term> <term id="T8" lex="gene" sem="DNA_family_or_group">genes</term></term> that include <term id="T9" lex="IL2" sem="DNA_domain_or_region">IL2</term>, <term id="T10" lex="IL3" sem="DNA_domain_or_region">IL3</term>, <term id="T11" lex="IL4" sem="DNA_domain_or_region">IL4</term>, and <term id="T12" lex="IL5" sem="DNA_domain_or_region">IL5</term>, which encode <term id="T13" lex="interleukin" sem="Protein_family_or_group">interleukins</term> 2, 3, 4, and 5 (<term id="T14" lex="IL-2" sem="Protein_molecule">IL-2</term>, <term id="T15" lex="IL-3" sem="Protein_molecule">-3</term>, <term id="T16" lex="IL-4" sem="Protein_molecule">-4</term>, and <term id="T17" lex="IL-5" sem="Protein_molecule">-5</term>).</sentence>
<event KT="Analysis" Polarity="Negative" Source="Other" assertion="non-exist" id="E2">
<type class="Transcription"/>
<theme idref="T9"/>
<clue>We have <clueSource>previously</clueSource> <clueKT>reported</clueKT> that the <clueLoc>T lymphocytes of a child with severe combined immunodeficiency</clueLoc> are <cluePolarity>defective</cluePolarity> in the <clueType>transcription</clueType> <linkTheme>of</linkTheme> several <corefTheme>lymphokine genes</corefTheme> that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5).</clue>
</event>
<event KT="Analysis" Polarity="Negative" Source="Other" assertion="non-exist" id="E1">
<type class="Transcription"/>
<theme idref="T10"/>
<clue>We have <clueSource>previously</clueSource> <clueKT>reported</clueKT> that the <clueLoc>T lymphocytes of a child with severe combined immunodeficiency</clueLoc> are <cluePolarity>defective</cluePolarity> in the <clueType>transcription</clueType> <linkTheme>of</linkTheme> several <corefTheme>lymphokine genes</corefTheme> that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5).</clue>
</event>
<event KT="Analysis" Polarity="Negative" Source="Other" assertion="non-exist" id="E3">
<type class="Transcription"/>
<theme idref="T11"/>
<clue>We have <clueSource>previously</clueSource> <clueKT>reported</clueKT> that the <clueLoc>T lymphocytes of a child with severe combined immunodeficiency</clueLoc> are <cluePolarity>defective</cluePolarity> in the <clueType>transcription</clueType> <linkTheme>of</linkTheme> several <corefTheme>lymphokine genes</corefTheme> that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5).</clue>
</event>
<event KT="Analysis" Polarity="Negative" Source="Other" assertion="non-exist" id="E4">
<type class="Transcription"/>
<theme idref="T12"/>
<clue>We have <clueSource>previously</clueSource> <clueKT>reported</clueKT> that the <clueLoc>T lymphocytes of a child with severe combined immunodeficiency</clueLoc> are <cluePolarity>defective</cluePolarity> in the <clueType>transcription</clueType> <linkTheme>of</linkTheme> several <corefTheme>lymphokine genes</corefTheme> that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5).</clue>
</event>
<sentence id="S3">To determine whether the defect in the patient&apos;s <term id="T18" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> involved a <term id="T19" lex="trans-acting_factor" sem="Protein_family_or_group">trans-acting factor</term> common to the affected <term id="T20" lex="lymphokine_gene" sem="DNA_family_or_group"><term id="T21" lex="lymphokine" sem="Protein_family_or_group">lymphokine</term> <term id="T22" lex="gene" sem="DNA_family_or_group">genes</term></term>, we examined the ability of <term id="T23" lex="nuclear_factor" sem="Protein_family_or_group">nuclear factors</term> from the patient&apos;s <term id="T24" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> to bind <term id="A1" sem="DNA_domain_or_region">response elements present in the <term id="T25" lex="regulatory_region" sem="DNA_domain_or_region">regulatory region</term> of <term id="T26" lex="IL2" sem="DNA_domain_or_region">IL2</term></term>.</sentence>
<event KT="Investigation" id="E5" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T19"/>
<clue><clueKT>To determine</clueKT> whether <corefTheme>the defect</corefTheme> <clueLoc>in the patient&apos;s T lymphocytes</clueLoc> <clueType>involved</clueType> a trans-acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient&apos;s T lymphocytes to bind response elements present in the regulatory region of IL2.</clue>
</event>
<event KT="Investigation" id="E6" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T19"/>
<clue><clueKT>To determine</clueKT> whether <corefTheme>the defect</corefTheme> <clueLoc>in the patient&apos;s T lymphocytes</clueLoc> <clueType>involved</clueType> a trans-acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient&apos;s T lymphocytes to bind response elements present in the regulatory region of IL2.</clue>
</event>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T19"/>
<clue><clueKT>To determine</clueKT> whether <corefTheme>the defect</corefTheme> <clueLoc>in the patient&apos;s T lymphocytes</clueLoc> <clueType>involved</clueType> a trans-acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient&apos;s T lymphocytes to bind response elements present in the regulatory region of IL2.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T19"/>
<clue><clueKT>To determine</clueKT> whether <corefTheme>the defect</corefTheme> <clueLoc>in the patient&apos;s T lymphocytes</clueLoc> <clueType>involved</clueType> a trans-acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient&apos;s T lymphocytes to bind response elements present in the regulatory region of IL2.</clue>
</event>
<event KT="Investigation" id="E32" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="T23"/>
<theme idref="A1"/>
<clue>To determine whether the defect in the patient&apos;s T lymphocytes involved a trans-acting factor common to the affected lymphokine genes, we <clueKT>examined</clueKT> the ability of nuclear factors from the patient&apos;s T lymphocytes to <clueType>bind</clueType> response elements present in the regulatory region of IL2.</clue>
<comment>TPS: A1</comment></event>
<sentence id="S4"><term id="T27" lex="nuclear_factor_NF-kB" sem="Protein_molecule">Nuclear factor <term id="A2" sem="Protein_molecule">NF-kB</term></term>, <term id="T28" lex="activation_protein_1" sem="Protein_molecule">activation protein 1</term> (<term id="T29" lex="AP-1" sem="Protein_molecule">AP-1</term>), <term id="T30" lex="OCT-1" sem="Protein_molecule">OCT-1</term>, and <term id="T31" lex="NF-IL-2B" sem="Protein_molecule">NF-IL-2B</term> <term id="T32" lex="binding_activity" sem="Other">binding activity</term> were normal.</sentence>
<event KT="Analysis" id="E8">
<type class="Binding"/>
<theme idref="A2"/>
<theme idref="A1"/>
<clue>Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B <clueType>binding</clueType> activity were <clueKT>normal</clueKT>.</clue>
<comment>NO COREFTHEME for A1</comment></event>
<event KT="Analysis" id="E10">
<type class="Binding"/>
<theme idref="T29"/>
<theme idref="A1"/>
<clue>Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B <clueType>binding</clueType> activity were <clueKT>normal</clueKT>.</clue>
<comment>NO COREFTHEME for A1</comment></event>
<event KT="Analysis" id="E11">
<type class="Binding"/>
<theme idref="T30"/>
<theme idref="A1"/>
<clue>Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B <clueType>binding</clueType> activity were <clueKT>normal</clueKT>.</clue>
<comment>NO COREFTHEME for A1</comment></event>
<event KT="Analysis" id="E12">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="A1"/>
<clue>Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B <clueType>binding</clueType> activity were <clueKT>normal</clueKT>.</clue>
<comment>NO COREFTHEME for A1</comment></event>
<sentence id="S5">In contrast, the binding of the <term id="T33" lex="nuclear_factor_of_activated_T_cells" sem="Protein_molecule">nuclear factor of <term id="T34" lex="activated_T_cell" sem="Cell_natural">activated <term id="T35" lex="T_cell" sem="Cell_natural">T cells</term></term></term> (<term id="T36" lex="NF-AT" sem="Protein_molecule">NF-AT</term>) to its <term id="A3" sem="DNA_domain_or_region">response element in the <term id="T37" lex="IL2_enhancer" sem="DNA_domain_or_region"><term id="T38" lex="IL2" sem="DNA_domain_or_region">IL2</term> enhancer</term></term> and to an <term id="A4" sem="DNA_domain_or_region"><term id="T39" lex="NF-AT-like_response_element" sem="DNA_domain_or_region"><term id="T40" lex="NF-AT" sem="Protein_molecule">NF-AT</term>-like response element</term> present in the <term id="T41" lex="IL4_enhancer" sem="DNA_domain_or_region">IL4 enhancer</term></term> was abnormal.</sentence>
<event KT="Analysis" id="E13">
<type class="Binding"/>
<theme idref="T36"/>
<theme idref="A3"/>
<clue>In contrast, the <clueType>binding</clueType> <linkTheme>of</linkTheme> the nuclear factor of activated T cells (NF-AT) <linkTheme>to</linkTheme> its response element in the IL2 enhancer and to an NF-AT-like response element present in the IL4 enhancer was <clueKT>abnormal</clueKT>.</clue>
<comment>TPS: A3</comment></event>
<event KT="Analysis" id="E14">
<type class="Binding"/>
<theme idref="T36"/>
<theme idref="A4"/>
<clue>In contrast, the <clueType>binding</clueType> <linkTheme>of</linkTheme> the nuclear factor of activated T cells (NF-AT) to its response element in the IL2 enhancer and <linkTheme>to</linkTheme> an NF-AT-like response element present in the IL4 enhancer was <clueKT>abnormal</clueKT>.</clue>
<comment>TPS: A4</comment></event>
<sentence id="S6">To ascertain whether the <term id="T42" lex="abnormal_NF-AT_binding_activity" sem="Other">abnormal <term id="T43" lex="NF-AT" sem="Protein_molecule">NF-AT</term> binding activity</term> was related to an impaired function, we transfected <term id="A12" sem="Cell_natural">patient</term> and <term id="A13" sem="Cell_natural">control</term> <term id="T44" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> with <term id="A5" sem="DNA_domain_or_region">constructs containing the reporter gene encoding <term id="T45" lex="chloramphenicol_acetyl_transferase" sem="Protein_molecule">chloramphenicol acetyl transferase</term> (<term id="T46" lex="CAT" sem="Protein_molecule">CAT</term>)</term> under the control of the entire <term id="T47" lex="IL2_regulatory_region" sem="DNA_domain_or_region"><term id="T48" lex="IL2" sem="DNA_domain_or_region">IL2</term> regulatory region</term> or of <term id="A6" sem="DNA_domain_or_region">multimers of individual <term id="T49" lex="enhancer_sequence" sem="DNA_domain_or_region">enhancer sequences</term></term>.</sentence>
<event KT="Other" id="E16">
<type class="Binding"/>
<theme idref="T43"/>
<clue>To ascertain whether the <clueType>abnormal</clueType> NF-AT <clueType>binding</clueType> activity was related to an impaired function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
</event>
<event KT="Investigation" id="E17" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E16"/>
<theme idref="E18"/>
<clue><clueKT>To ascertain</clueKT> whether the abnormal NF-AT binding activity was <clueType>related</clueType> <linkTheme>to</linkTheme> an impaired function, we <clueExperiment>transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences</clueExperiment>.</clue>
</event>
<event KT="Other" id="E18">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an <clueType>impaired</clueType> function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
</event>
<event KT="Other" id="E19">
<type class="Regulation"/>
<cause idref="T43"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired <clueType>function</clueType>, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
</event>
<event KT="Method" id="E33" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we <clueType>transfected</clueType> <clueLoc>patient</clueLoc> and control <clueLoc>T lymphocytes</clueLoc> <linkTheme>with</linkTheme> constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
<comment>TPS: A5; ARTIFICIAL</comment></event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we <clueType>transfected</clueType> <clueLoc>patient</clueLoc> and control <clueLoc>T lymphocytes</clueLoc> <linkTheme>with</linkTheme> constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
</event>
<event KT="Method" id="E35" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we <clueType>transfected</clueType> patient and <clueLoc>control T lymphocytes</clueLoc> <linkTheme>with</linkTheme> constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
<comment>TPS: A5; ARTIFICIAL</comment></event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E35"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we <clueType>transfected</clueType> patient and <clueLoc>control T lymphocytes</clueLoc> <linkTheme>with</linkTheme> constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
</event>
<event id="E22">
<type class="Regulation"/>
<theme idref="A5"/>
<cause idref="T47"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) <clueType>under the control</clueType> <linkCause>of</linkCause> the entire IL2 regulatory region or of multimers of individual enhancer sequences.</clue>
<comment>TPS: A5</comment></event>
<event id="E23">
<type class="Regulation"/>
<theme idref="A5"/>
<cause idref="A6"/>
<clue>To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) <clueType>under the control</clueType> of the entire IL2 regulatory region or <linkCause>of</linkCause> multimers of individual enhancer sequences.</clue>
<comment>TPS: A5 &amp; A6</comment></event>
<sentence id="S7"><term id="A8" sem="DNA_domain_or_region">CAT</term> expression directed by the <term id="T50" lex="IL2_regulatory_region" sem="DNA_domain_or_region"><term id="T51" lex="IL2" sem="DNA_domain_or_region">IL2</term> regulatory region</term> or by a <term id="A7" sem="DNA_domain_or_region">multimer of the <term id="T52" lex="NF-AT-binding_site" sem="DNA_domain_or_region"><term id="T53" lex="NF-AT" sem="Protein_molecule">NF-AT</term>-binding site</term></term> was markedly lower in the <term id="T54" lex="patient" sem="Multicellular_organism_natural">patient</term> relative to controls.</sentence>
<event id="E24">
<type class="Gene_expression"/>
<theme idref="A8"/>
<clue>CAT <clueType>expression</clueType> directed by the IL2 regulatory region or by a multimer of the NF-AT-binding site was markedly lower in the patient relative to controls.</clue>
</event>
<event id="E27">
<type class="Regulation"/>
<theme idref="A8"/>
<cause idref="T50"/>
<clue>CAT expression <clueType>directed</clueType> <linkCause>by</linkCause> the IL2 regulatory region or by a multimer of the NF-AT-binding site was markedly lower in the patient relative to controls.</clue>
</event>
<event id="E28">
<type class="Regulation"/>
<theme idref="A8"/>
<cause idref="A7"/>
<clue>CAT expression <clueType>directed</clueType> by the IL2 regulatory region or <linkCause>by</linkCause> a multimer of the NF-AT-binding site was markedly lower in the patient relative to controls.</clue>
<comment>TPS: A8</comment></event>
<event Manner="High" id="E29">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<clue>CAT expression directed by the IL2 regulatory region or by a multimer of the NF-AT-binding site was <clueManner>markedly</clueManner> <clueType>lower</clueType> <clueLoc>in the patient</clueLoc> relative to controls.</clue>
<comment>CAUTION, lower</comment></event>
<sentence id="S8">In contrast, <term id="T55" lex="CAT_gene_expression" sem="Other"><term id="T56" lex="CAT_gene" sem="DNA_family_or_group">CAT gene</term> expression</term> directed by a <term id="A9" sem="DNA_domain_or_region">multimer of the <term id="T57" lex="OCT-1_proximal_(OCT-1p)-binding_site" sem="DNA_domain_or_region">OCT-1 proximal (OCT-1p)-binding site</term></term> was equivalent in patient and controls.</sentence>
<event KT="Other" id="E25">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>In contrast, CAT gene <clueType>expression</clueType> directed by a multimer of the OCT-1 proximal (OCT-1p)-binding site was equivalent in patient and controls.</clue>
</event>
<event KT="Other" id="E30">
<type class="Regulation"/>
<theme idref="T58"/>
<cause idref="A9"/>
<clue>In contrast, CAT gene expression <clueType>directed</clueType> <linkCause>by</linkCause> a multimer of the OCT-1 proximal (OCT-1p)-binding site was equivalent in patient and controls.</clue>
<comment>TPS; A9</comment></event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E31">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<clue>In contrast, CAT gene expression directed by a multimer of the OCT-1 proximal (OCT-1p)-binding site was <clueType><clueKT><cluePolarity>equivalent</cluePolarity></clueKT></clueType> <clueLoc>in patient</clueLoc> and controls.</clue>
<comment>CAUTION, equivalent</comment></event>
<sentence id="S9">These results indicate that an abnormality of/or influencing <term id="T58" lex="NF-AT" sem="Protein_molecule">NF-AT</term> may underlie the multiple <term id="T59" lex="lymphokine_deficiency" sem="Other"><term id="T60" lex="lymphokine" sem="Protein_family_or_group">lymphokine</term> deficiency</term> in this <term id="T61" lex="patient" sem="Multicellular_organism_natural">patient</term>.</sentence>
<event KT="Other" id="E26">
<type class="Regulation"/>
<theme idref="T58"/>
<clue>These results indicate that an abnormality of/or <clueType>influencing</clueType> NF-AT may underlie the multiple lymphokine deficiency in this patient.</clue>
</event>
<event CL="L1" KT="Analysis" id="E34" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T59"/>
<cause idref="E26"/>
<clue>These results <clueKT>indicate</clueKT> that an abnormality of/or influencing NF-AT <clueCL>may</clueCL> <clueType>underlie</clueType> the multiple lymphokine deficiency <clueLoc>in this patient</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
